• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Rifaximin     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatPyridines, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingdul:ChemicalObjectchemical substanceDrugyago:WikicatAmidesyago:WikicatMolecularFormulasyago:WikicatNaphthalenesyago:Abstraction100002137yago:Alcohol114708720yago:Amide114724264yago:Base114618253yago:Chemical114806838yago:Communication100033020yago:Compound114818238yago:Diol114835980yago:Element114840755yago:Ester114850483yago:Fluid114939900yago:Formula106816935yago:Hydrocarbon114911057yago:Imidazole114916670yago:Ketone114926294yago:Liquid114940386yago:Material114580897yago:Matter100020827yago:Message106598915yago:MolecularFormula106817173yago:Naphthalene114958564yago:OrganicCompound114727670yago:Part113809207yago:Phenol114989545yago:PhysicalEntity100001930yago:Pyridine114692510yago:Quintessence114847103yago:Relation100031921yago:WikicatImidazolesyago:WikicatKetonesdrugyago:Statement106722453yago:Substance100019613yago:WikicatAcetateEstersyago:WikicatDiolsyago:WikicatEthersyago:WikicatPhenolsyago:WikicatPyridines New Facet based on Instances of this Class

Rifaximin, is a non-absorbable, broad spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in over more than 30 countries for the treatment of a variety of gastrointestinal diseases like irritable bowel syndrome, and hepatic encephalopathy. It acts by inhibiting RNA synthesis in susceptible bacteria by binding to the RNA polymerase enzyme. This binding blocks translocation, which stops transcription. It is marketed under the brand name Xifaxan by Salix Pharmaceuticals.